CytoMed Therapeutics Limited Ordinary Shares (NASDAQ: GDTC) last traded at $0.811, down 8.88% on the session. The quote above updates while this page is open; the figures below are drawn from CytoMed Therapeutics Limited Ordinary Shares’s own filings and are restated only when a new one is published.
CytoMed Therapeutics Limited Ordinary Shares trades on NASDAQ under the ticker GDTC. Its market capitalisation is $9.59 million.
Valuation measures for CytoMed Therapeutics Limited Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.59M |
|---|---|
| Beta | 0.03 |
Trailing-twelve-month figures tagged in CytoMed Therapeutics Limited Ordinary Shares's XBRL filings with the SEC.
| Net income (TTM) | -$3.11M |
|---|
Range and volume for GDTC over the past 52 weeks.
| 52-week high | $3.68 |
|---|---|
| 52-week low | $0.680 |
| Volume | 54.8K |
| Average volume | 80.1K |
| Previous close | $0.890 |
Invest a chosen dollar amount in CytoMed Therapeutics Limited Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GDTC.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.